Summary
AXVAN is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €377,266 and a net result of €117,526. Equity is growing by about 31% per year across the filed financial years. Its solvency ranks better than 76% of 9,728 sector peers (NACE 64, financial year 2025). The company has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
10-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
28-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 28 days late
2024
01-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 1 day late
2023
31-12
Financial
Highest result from 2020 to 2025net €208,290 ▲67%
Net result €208,290, the highest in the series.
31-12
Financial
Liquidity more than doubledcurrent ratio 13.29
Current ratio from 4.98 to 13.29; short-term debt falls from €41,598 to €30,200.
31-12
Financial
Equity above €200,000equity €378,584 ▲122%
A profit in every financial year since 2020 builds equity to €378,584.
31-08
Gazette deed
Incorporation · Founder
Name clause · Legal form clause
09-08
NBB filing
Annual accounts filed
financial year 2022 · micro format · 9 days late
2022
31-12
Financial
Liquidity more than doubledcurrent ratio 4.98
Current ratio from 1.70 to 4.98; short-term debt falls from €59,685 to €41,598.
31-12
Financial
Equity above €150,000equity €170,294 ▲261%
A profit in every financial year since 2020 builds equity to €170,294.
17-08
NBB filing
Annual accounts filed
financial year 2021 · micro format · 17 days late
2021
30-06
NBB filing
Annual accounts filed
financial year 2020 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.